Dr. Aktas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Crittenden Blvd
Rochester, NY 14642Phone+1 585-275-4775Fax+1 585-473-1573
Summary
- Dr. Mehmet Aktas is a cardiac electrophysiologist in Rochester, NY. He is an Associate Professor of Medicine at the University of Rochester Medical Center.
He received his medical degree from State University of New York Upstate Medical University and completed training at the Cleveland Clinic and University of Rochester Medical Center. He has been in practice 15 years.
He specializes in cardiac electrophysiology. He has extensive experience in the treatment of atrial fibrillation, ventricular tachycardia and device based therapies including implantable cardioverter-defibrillator insertion and follow-up. He is actively involved in numerous clinical research projects focused on the treatment of heart failure, atrial fibrillation and sudden cardiac death.
Education & Training
- University of RochesterFellowship, Clinical Cardiac Electrophysiology, 2008 - 2009
- University of RochesterFellowship, Cardiovascular Disease, 2005 - 2008
- Cleveland Clinic FoundationResidency, Internal Medicine, 2002 - 2005
- SUNY Upstate Medical UniversityClass of 2002
Certifications & Licensure
- NY State Medical License 2006 - 2025
- OH State Medical License 2002 - 2005
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Clinical Cardiac Electrophysiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Ranolazine Implantable Cardioverter-Defibrillator Trial Start of enrollment: 2011 Sep 01
- Radiofrequency (RF) Ablation for Atrial Fibrillation (AF) in Patients With Heart Failure With Preserved Ejection Fraction Start of enrollment: 2021 Jan 25
Publications & Presentations
PubMed
- 22 citationsThe perceived role of Islam in immigrant Muslim medical practice within the USA: an exploratory qualitative studyAasim I. Padela, Hasan Shanawani, Jane Greenlaw, Hamada Hamid, Mehmet K. Aktas
Journal of Medical Ethics. 2008-05-01 - 53 citationsEffect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart f...Valentina Kutyifa, László Gellér, Peter Bogyi, Endre Zima, Mehmet K. Aktas
European Journal of Heart Failure. 2014-12-01 - 39 citationsAssociation between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy.Martin H. Ruwald, Suneet Mittal, Anne-Christine Ruwald, Mehmet K. Aktas, James P. Daubert
Journal of the American College of Cardiology. 2014-09-09
Journal Articles
- Device Measured Rapid Shallow Breathing Index and Not Minute Ventilation Reflects Changes in Dyspnea Status in Ambulatory Heart Failure PatientsMehmet Aktas, John Boehmer, Journal of Cardiac Failure
- CIED Malfunction in Patients Receiving Radiation Is a Rare Event That Could Be Detected by Remote MonitoringAbrar H Shah, Mehmet K Aktas, Genaro Fernandez, Sughosh Dhakal, Michael J Moravan, Journal of Cardiovascular Electrophysiology
Authored Content
- Device Measured Rapid Shallow Breathing Index and Not Minute Ventilation Reflects Changes in Dyspnea Status in Ambulatory Heart Failure PatientsAugust 2018
Press Mentions
- URMC to Lead $27M Heart Failure Medication StudyAugust 13th, 2024
- Cite as Tosun M, Olmez M, Unver E, Et Al. Oxidative and Pro- Inflammatory Lung Injury Induced by Desflurane Inhalation in Rats and the Protective Effect of Rutin [Published Online as Ahead of Print on August 19, 2021]. Adv Clin Exp Med. 2021;30(9). doi:10.17219/acem/136194September 25th, 2020
- Chest Pain Drug Ranolazine Falls Short in Preventing First Episode of Ventricular Arrhythmia or DeathSeptember 5th, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: